Publication | Open Access

The anti-tumour effects of the prodrugs N-l-leucyl-doxorubicin and vinblastine-isoleucinate in human ovarian cancer xenografts

MedicinePharmacologyAnti-tumour EffectsPharmacotherapyAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyCancer ResearchTumor MicroenvironmentTumor BiologyEndocrine-related CancerOvarian CancerProdrugs N-l-leucyl-doxorubicin